Acute Porphyria Drugs

D07XC02 - Desoximetasone

Not porphyrinogenic
NP

Rationale
The glucocorticoid and ASA components are stated in several references not to be porphyrinogenic. Probably only insignificant systemic exposure.
Chemical description
Strong glucocorticoid, solution 2.5 mg/g, in combination with acetylsalicylic acid for scalp use. Glucocorticoid: South African list: use. Kalman, Bonkovsky: believed to be safe. The Merck Manual: use. Moore MR, Hift RJ: Drugs in acute porphyria. Cell Mol Biol 43:89, 1997: safe. Tschudy DP, Lamon JM: Porphyrin metabolism and the Porphyrias in Bondy BK, Rosenberg LE (eds): Duncan’s Diseases of Metabolism, Philadelphia, WB Saunders 1980, p 939: safe.. Acetylsalicylic acid: South African list: safe. Kalman, Bonkovsky: safe. Michael Moore’s list: safe. The Merck Manual: safe . Eales L: Porphyria and the dangerous lifethreatening drugs, S Afr Med 56:914, 1979: safe.
Similar drugs
Explore alternative drugs in similar therapeutic classes D07X / D07XC or go back.
References
# Citation details PubMed ID
1. Porphyria and the dangerous life-threatening drugs.
Eales L. S Afr Med J. 1979 Nov; 56(22):914-7.
515871
2. Management of acute attacks in the porphyrias.
Kalman DR, Bonkovsky HL. Clin Dermatol. 1998; 16(2):299-306.
9554242
3. Drugs in the acute porphyrias--toxicogenetic diseases.
Moore MR, Hift RJ. Cell Mol Biol (Noisy-le-grand). 1997 Feb; 43(1):89-94.
9074793
Other sources
4. Porphyrin metabolism and the Porphyrias [Book Chapter]
Tschudy DP, Lamon JM Bondy BK, Rosenberg LE (eds): Duncan's Diseases of Metabolism, Philadelphia, WB Saunders. 1980.
Tradenames

Stiedex
In cooperation with Ipnet
© Napos 2026
An unhandled error has occurred. Reload 🗙